Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00935311Phase 2Completed
Phase 2, randomised, single-blind trial of hydrocodone + acetaminophen in acute pain (3 arms), sponsored by AbbVie Inc. Primary endpoint: Sum of Pain Intensity Difference at 12 hours. Started Jun 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00935311.